Sign inJoin waitlistJoin the waitlist

SL

Shashikant Lele

MD Award · University at Buffalo School of Medicine

Credentials: · ·

History

University at Buffalo School of Medicine
Present

Gynecologic Oncology
1974–1977
Obstetrics and Gynecology
1970–1974
Doctor of Medicine
1963–1967

Research

Intraperitoneal cisplatin and paclitaxel in ovarian cancer
New England Journal of Medicine · 2006 · 2,043 citations
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
Proceedings of the National Academy of Sciences of the United States of America · 2005 · 2,024 citations
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
Proceedings of the National Academy of Sciences of the United States of America · 2010 · 734 citations

MP
M Piver
47 papers
PF
Paulette Mhawech Fauceglia
41 papers
Peter Frederick
19 papers · 6 as a resident
TP
Tanja Pejovic
19 papers · 2 as a fellow
Joshua Kesterson
15 papers · 14 as a resident
Beth Karlan
14 papers
Kerry Rodabaugh
13 papers
DM
David Marchetti
12 papers · 3 as a fellow
Andrew Berchuck
11 papers
DL
Douglas Levine
11 papers
HG
Heidi Godoy
11 papers · 11 as a resident
Karen Lu
11 papers

Grants

Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
National Cancer Institute · UG1
PI · $2.6M · Roswell Park Cancer Institute Corp
2019–2026
Roswell Park Ovarian Cancer SPORE
National Cancer Institute · P50
Project lead · $278.3K · Roswell Park Cancer Institute Corp
2013–2019
Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.
National Cancer Institute · U10
PI · $2.9M · Roswell Park Cancer Institute Corp
2014–2019

Clinical trials

Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer
Principal investigator · Terminated · Phase 2
Roswell Park Cancer Institute
2007–2009